Sign In
Buy BMY
$56.60
+1.88 (+3.44%)
At Close: Jun 04, 2026
Bristol Myers Squibb (BMY) Crossed Above the 200-Day Moving Average: What That Means for Investors
10:32am, Friday, 02'nd Aug 2024
From a technical perspective, Bristol Myers Squibb (BMY) is looking like an interesting pick, as it just reached a key level of support. BMY recently overtook the 200-day moving average, and this sugg
The 3 Biggest Earnings Beats for Q2 as of August 1, 2024
04:40pm, Thursday, 01'st Aug 2024
Stock prices follow earnings. This nugget of investing wisdom essentially says the most important thing long-term investors should focus on is the profits a company makes.
Bargain-Hunters Paradise: 7 Value Stocks That Are Too Cheap to Ignore
10:00am, Thursday, 01'st Aug 2024
The market consistently offers opportunities in value stocks for bargain hunters willing to do the work and take risks. Most of the work is done here for you as I have identified value stocks that are
Dividend Harvesting Portfolio Week 178: $17,800 Allocated, $1,612.87 In Projected Dividends
09:00am, Thursday, 01'st Aug 2024
Alphabet and Tesla had negative reactions to Q2 earnings reports. Economic data showed PCE increased 0.1% MoM, while consumer confidence declined for the 4th consecutive month. The Dividend Harvesting
2 High Conviction Buys Yielding 5-8%
08:05am, Thursday, 01'st Aug 2024
Buying high-growth stocks may not always lead to long-term returns due to high share prices and low dividend yields, lessening the impact of dividend reinvestment. Bristol-Myers Squibb offers strong r
Don't Buy AI Stocks, Buy The Best Dividend Total Return Stocks
03:29am, Thursday, 01'st Aug 2024
I have a diversified portfolio of stocks, funds, and bonds. My stocks are primarily dividend paying value stocks. One can find dividend stocks with superior estimated total returns by comparing their
Should You Pick Bristol Myers Squibb Stock At $50 After A Solid Q2 Beat?
09:00am, Wednesday, 31'st Jul 2024
Bristol Myers Squibb (NYSE: BMY) recently reported its Q2 results, with revenues and earnings exceeding our estimates. The company reported revenue of $12.2 billion and adjusted earnings of $2.07 per
The Top 3 Healthcare Stocks to Buy Now: Summer 2024
07:00am, Wednesday, 31'st Jul 2024
One of the most pertinent drivers of the stock market that is often not considered by many investors is the demographic trajectory of the U.S. Currently, the U.S. population is older than ever before
BMY vs. VRTX: Which Stock Should Value Investors Buy Now?
12:41pm, Tuesday, 30'th Jul 2024
Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Bristol Myers Squibb (BMY) and Vertex Pharmaceuticals (VRTX). But which of these two companies is th
Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know
10:06am, Tuesday, 30'th Jul 2024
Bristol Myers (BMY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Is Bristol Myers Squibb a Good Dividend Stock to Buy Now?
04:49am, Tuesday, 30'th Jul 2024
Bristol Myers Squibb lowered its earnings outlook earlier this year to account for recent acquisitions. One of Bristol Myers Squibb's top-selling drugs, Revlimid, has already lost patent-protected mar
Bristol-Myers Squibb Earnings Reinforces Our Thesis
02:37pm, Monday, 29'th Jul 2024
Bristol-Myers Squibb Company stock crossed $50/share after strong earnings. The company saw 18% YoY revenue growth in 2Q 2024. Bristol-Myers has a strong pipeline with potential for future growth, foc
Pharma companies less concerned after hearing from US on negotiated prices for Medicare
01:37pm, Monday, 29'th Jul 2024
Four pharmaceutical companies involved in the first U.S. negotiations over prices for the Medicare program said they do not expect a significant impact on their businesses after seeing confidential su
Is Bristol-Myers Squibb's Stock Rally Justified? Bull Vs. Bear Analysts On Q2 Earnings
11:59am, Monday, 29'th Jul 2024
Bristol-Myers Squibb Co BMY on Friday reported upbeat second-quarter results.
Pharma Giant's Shares Up After Impressive Q2 Earnings Release
10:31am, Monday, 29'th Jul 2024
Bristol-Myers Squibb NYSE: BMY is in the healthcare sector and is the 10th largest pharmaceutical firm in the world by market capitalization. The company released Q2 2024 financial results on July 26,
